Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Olmos LC, Sayed MS, Moraczewski AL, Gedde SJ, Rosenfeld PJ, Shi W et al. Long-term outcomes of neovascular glaucoma treated with and without intavitreal bevacizumab. Eye 2016; 30: 463–472.
Hamard P, Baudouin Ch . Consensus sur le glaucome neovasculaire. J Fr Ophtalmol 2000; 23 (3): 289–294.
Călugăru D, Călugăru M . Prevention of neovascular glaucoma. Ophthalmology 2013; 120 (7): 1507–1508.
Călugăru D, Călugăru M . Intravitreal bevacizumab in acute central/hemicentral retinal vein occlusions: three-year results of a prospective clinical study. J Ocul Pharmacol Ther 2015; 31 (2): 78–86.
Călugăru M . Les resultats d’une enquete sur la survenue du glaucome neovasculaire après occlusion de la veine centrale de la retine. J Fr Ophtalmol 1987; 10 (8/9): 479–483.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Călugăru, D., Călugăru, M. Comment on: ‘Long-term outcomes of neovascular glaucoma treated with and without intravitreal bevacizumab’. Eye 30, 896–897 (2016). https://doi.org/10.1038/eye.2016.31
Published:
Issue date:
DOI: https://doi.org/10.1038/eye.2016.31
